Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies32
  • 7D1.6%
  • 3M31.7%
  • 1Y81.3%
  • YTD20.1%

Over the last 7 days, the Pharma industry has risen 1.6%, driven by gains from Camurus of 3.4%. This means that the industry has gained 81% over the past year. Earnings are forecast to grow by 66% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024SEK 68.4bSEK 5.5b-SEK 997,636,216.04103.2x-68.6x12.3x
Sun, 23 Jun 2024SEK 64.6bSEK 6.4b-SEK 862,366,054.2974.8x-74.9x10.1x
Tue, 21 May 2024SEK 54.5bSEK 6.4b-SEK 764,935,481.2173.6x-71.3x8.6x
Thu, 18 Apr 2024SEK 49.8bSEK 6.2b-SEK 1,040,647,175.1776.2x-47.8x8x
Sat, 16 Mar 2024SEK 51.3bSEK 6.2b-SEK 1,038,063,400.1178.4x-49.4x8.2x
Mon, 12 Feb 2024SEK 51.7bSEK 6.0b-SEK 906,523,947.1966.4x-57x8.6x
Wed, 10 Jan 2024SEK 69.8bSEK 9.4b-SEK 1,184,296,921.0065.5x-58.9x7.4x
Fri, 08 Dec 2023SEK 62.6bSEK 9.4b-SEK 1,209,361,304.0056.4x-51.7x6.6x
Sun, 05 Nov 2023SEK 53.9bSEK 9.3b-SEK 1,122,821,864.0082.7x-48x5.8x
Tue, 03 Oct 2023SEK 51.1bSEK 9.2b-SEK 1,177,256,855.00116.7x-43.4x5.6x
Thu, 31 Aug 2023SEK 50.7bSEK 9.2b-SEK 1,160,714,223.00142.3x-43.7x5.5x
Sat, 29 Jul 2023SEK 50.7bSEK 8.9b-SEK 1,431,463,244.0087.7x-35.4x5.7x
Mon, 26 Jun 2023SEK 48.4bSEK 8.4b-SEK 1,693,005,057.0077x-28.6x5.8x
Wed, 24 May 2023SEK 48.2bSEK 8.4b-SEK 1,693,541,347.0083.6x-28.5x5.8x
Fri, 21 Apr 2023SEK 45.7bSEK 8.0b-SEK 1,794,927,805.0099.2x-25.4x5.7x
Sun, 19 Mar 2023SEK 45.5bSEK 8.0b-SEK 1,793,560,562.0083.8x-25.4x5.7x
Tue, 14 Feb 2023SEK 46.7bSEK 7.3b-SEK 1,954,775,424.00281.2x-23.9x6.4x
Thu, 12 Jan 2023SEK 48.2bSEK 7.3b-SEK 1,913,000,806.00292.3x-25.2x6.6x
Sat, 10 Dec 2022SEK 49.1bSEK 7.3b-SEK 1,874,868,890.00291.1x-26.2x6.7x
Mon, 07 Nov 2022SEK 49.6bSEK 7.0b-SEK 1,732,146,998.0044x-28.6x7.1x
Wed, 05 Oct 2022SEK 50.2bSEK 7.0b-SEK 1,739,483,207.0048.8x-28.9x7.2x
Fri, 02 Sep 2022SEK 51.1bSEK 7.0b-SEK 1,745,997,611.0057x-29.2x7.3x
Sun, 31 Jul 2022SEK 51.8bSEK 6.9b-SEK 1,552,569,830.0042.1x-33.4x7.5x
Tue, 28 Jun 2022SEK 52.3bSEK 5.9b-SEK 1,509,116,648.0044.4x-34.7x8.8x
Thu, 26 May 2022SEK 51.3bSEK 5.7b-SEK 1,490,465,181.0045.8x-34.4x9.1x
Sat, 23 Apr 2022SEK 56.9bSEK 5.5b-SEK 1,335,933,728.0036.6x-42.6x10.3x
Mon, 21 Mar 2022SEK 53.7bSEK 5.4b-SEK 1,372,758,723.0037.9x-39.1x10x
Wed, 16 Feb 2022SEK 52.7bSEK 5.3b-SEK 1,078,929,318.00149x-48.9x10x
Fri, 14 Jan 2022SEK 52.7bSEK 5.5b-SEK 1,099,822,821.00122.1x-47.9x9.7x
Sun, 12 Dec 2021SEK 55.6bSEK 5.5b-SEK 1,097,650,781.00125.3x-50.7x10.2x
Tue, 09 Nov 2021SEK 52.9bSEK 5.0b-SEK 1,425,483,292.00132.9x-37.1x10.5x
Thu, 07 Oct 2021SEK 53.5bSEK 4.8b-SEK 1,582,472,496.00160.7x-33.8x11.2x
Sat, 04 Sep 2021SEK 58.0bSEK 4.8b-SEK 1,413,242,854.26159.3x-41x12.1x
Mon, 02 Aug 2021SEK 55.1bSEK 4.8b-SEK 1,412,039,942.26164.7x-39x11.5x
Price to Earnings Ratio

-39x


Total Market Cap: SEK 55.1bTotal Earnings: -SEK 1,412,039,942.26Total Revenue: SEK 4.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -40.6x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.0x is lower than the industry's current PS ratio of 12.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.57%
Healthcare0.77%
Pharma1.56%
Pharma1.56%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 660.003.4%
+SEK 1.3b
119.4%PE173.3x
CSMED CS MedicaDKK 14.99170.8%
+DKK 116.5m
97.9%PS37.8x
SECARE SwedencareSEK 53.101.4%
+SEK 119.0m
21.1%PE117.9x
IRLAB A IRLAB TherapeuticsSEK 16.554.7%
+SEK 38.9m
106.9%PS20.6x
ERMA Enorama PharmaSEK 5.0218.4%
+SEK 31.9m
24.0%PS306.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CALTX

SEK 206.20

Calliditas Therapeutics

7D

-0.1%

1Y

120.1%

DICOT

SEK 0.29

Dicot Pharma

7D

4.7%

1Y

89.1%

CSMED

DKK 14.99

CS Medica

7D

170.8%

1Y

97.9%

ORX

SEK 16.44

Orexo

7D

-3.3%

1Y

-7.6%

ENZY

SEK 1.93

Enzymatica

7D

-6.3%

1Y

-32.5%

CAMX

SEK 660.00

Camurus

7D

3.4%

1Y

119.4%

ASAP

SEK 0.13

Asarina Pharma

7D

-78.6%

1Y

-88.1%

IRLAB A

SEK 16.55

IRLAB Therapeutics

7D

4.7%

1Y

106.9%

FLERIE

SEK 48.05

Flerie

7D

-0.3%

1Y

n/a

MOB

SEK 37.30

Moberg Pharma

7D

0.6%

1Y

478.3%

KDEV

SEK 1.51

Karolinska Development

7D

3.4%

1Y

-6.5%

ERMA

SEK 5.02

Enorama Pharma

7D

18.4%

1Y

24.0%

ZICC

SEK 5.72

Ziccum

7D

-6.2%

1Y

-31.4%

SECARE

SEK 53.10

Swedencare

7D

1.4%

1Y

21.1%

PILA

SEK 5.10

Pila Pharma

7D

-7.9%

1Y

113.4%